BNPLAB Co., Ltd.
↗Seoul, South Korea
BNPLAB Co., Ltd. is a specialized South Korean pharmaceutical regulatory consulting firm and Contract Research Organization (CRO). The company focuses on accelerating the time-to-market for drug and medical device innovators by providing comprehensive end-to-end solutions, including strategy design, IND/NDA submissions, and reviewer engagement.
BNPLAB distinguishes itself through its 'Zero Regulatory Risk' philosophy and the integration of AI-powered data analysis into CRO operations to enhance efficiency in clinical trial management and regulatory processes. They operate primarily out of Seoul and the Osong bio-cluster, serving as a strategic partner for biotech startups and established pharmaceutical firms navigating the South Korean (MFDS) and global regulatory landscapes.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1-50
Revenue:$1M-$5M (estimate)
Founded:2021
Ownership:private
Status:operating
FUNDING
Stage:Late Seed / Series A
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Service Provider)
Modalities:Small molecule, Medical Devices, Biologics, Functional Foods
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Pharmaceutical Society of Korea (PSK), Korea Drug Development Fund (KDDF), Sejong University
COMPETITION
Position:Niche Player
Competitors:C&R Research, LSK Global PS, DreamCIS, ADM Korea, KCRN Research
LEADERSHIP
Key Executives:
Hwa-Kyung Lim - CEO
Nam Kyu Yoon - Director
Scientific Founders:Hwa-Kyung Lim
LINKS
Website:bnplab.onmicrosoft.com
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of BNPLAB Co., Ltd. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with BNPLAB Co., Ltd.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.